昼夜节律基因NPAS2中的非同义多态性与乳腺癌风险
Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk.
作者信息
Zhu Yong, Stevens Richard G, Leaderer Derek, Hoffman Aaron, Holford Theodore, Zhang Yawei, Brown Heather N, Zheng Tongzhang
机构信息
Department of Epidemiology and Public Health, Yale University School of Medicine, LEPH Room 702, New Haven, CT 06520, USA.
出版信息
Breast Cancer Res Treat. 2008 Feb;107(3):421-5. doi: 10.1007/s10549-007-9565-0. Epub 2007 Apr 24.
Abstract
Three known non-synonymous polymorphisms (Ala394Thr, Ser471Leu and Pro690Ala) in the largest circadian gene, Neuronal PAS domain protein 2 (NPAS2), were genotyped in a breast cancer case-control study conducted in Connecticut, USA (431 cases and 476 controls). We found that women with the heterozygous Ala394Thr genotype were significantly associated with breast cancer risk compared to those with the common homozygous Ala394Ala (OR = 0.61, 0.46-0.81, P = 0.001). This is the first evidence demonstrating a role of the circadian gene NPAS2 in human breast cancer, suggesting that genetic variations in circadian genes might be a novel panel of biomarkers for breast cancer risk.
摘要
在美国康涅狄格州进行的一项乳腺癌病例对照研究中，对最大的昼夜节律基因——神经元PAS结构域蛋白2（NPAS2）中的三个已知非同义多态性（Ala394Thr、Ser471Leu和Pro690Ala）进行了基因分型（431例病例和476例对照）。我们发现，与常见的纯合子Ala394Ala相比，携带杂合子Ala394Thr基因型的女性与乳腺癌风险显著相关（OR = 0.61，0.46 - 0.81，P = 0.001）。这是证明昼夜节律基因NPAS2在人类乳腺癌中起作用的首个证据，表明昼夜节律基因的遗传变异可能是一组新的乳腺癌风险生物标志物。
相似文献
1
Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk.
Breast Cancer Res Treat. 2008 Feb;107(3):421-5. doi: 10.1007/s10549-007-9565-0. Epub 2007 Apr 24.
2
The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer.
Breast Cancer Res Treat. 2010 Apr;120(3):663-9. doi: 10.1007/s10549-009-0484-0. Epub 2009 Aug 1.
3
Circadian genes and breast cancer susceptibility in rotating shift workers.
Int J Cancer. 2012 Dec 1;131(11):2547-52. doi: 10.1002/ijc.27564. Epub 2012 Sep 7.
4
Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma.
Int J Cancer. 2007 Jan 15;120(2):432-5. doi: 10.1002/ijc.22321.
5
A variant affecting miRNAs binding in the circadian gene Neuronal PAS domain protein 2 (NPAS2) is not associated with breast cancer risk.
Breast Cancer Res Treat. 2011 Jun;127(3):769-75. doi: 10.1007/s10549-010-1157-8. Epub 2010 Dec 8.
6
Polymorphisms in circadian genes, night work and breast cancer: results from the GENICA study.
Chronobiol Int. 2014 Dec;31(10):1115-22. doi: 10.3109/07420528.2014.957301. Epub 2014 Sep 17.
7
Roles of NPAS2 in circadian rhythm and disease.
Acta Biochim Biophys Sin (Shanghai). 2021 Oct 12;53(10):1257-1265. doi: 10.1093/abbs/gmab105.
8
Lack of association of the NPAS2 gene Ala394Thr polymorphism (rs2305160:G>A) with risk of chronic lymphocytic leukemia.
Asian Pac J Cancer Prev. 2014;15(17):7169-74. doi: 10.7314/apjcp.2014.15.17.7169.
9
Cancer-related transcriptional targets of the circadian gene NPAS2 identified by genome-wide ChIP-on-chip analysis.
Cancer Lett. 2009 Nov 1;284(2):149-56. doi: 10.1016/j.canlet.2009.04.017. Epub 2009 May 19.
10
The circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage response.
Mol Cancer Res. 2008 Sep;6(9):1461-8. doi: 10.1158/1541-7786.MCR-07-2094.
引用本文的文献
1
Evaluation of the Circadian Rhythm Component Cipc (Clock-Interacting Pacemaker) in Leukemogenesis: A Literature Review and Bioinformatics Approach.
Clocks Sleep. 2025 Jun 25;7(3):33. doi: 10.3390/clockssleep7030033.
2
Polymorphisms in circadian rhythm genes and the risk of differentiated thyroid cancer.
Front Genet. 2025 Jun 4;16:1539090. doi: 10.3389/fgene.2025.1539090. eCollection 2025.
3
Identification of potential susceptibility loci for non-small cell lung cancer through whole genome sequencing in circadian rhythm genes.
Sci Rep. 2025 Mar 6;15(1):7825. doi: 10.1038/s41598-025-92083-9.
4
Genetic and epigenetic alterations in night shift nurses with breast cancer: a narrative review.
Cancer Cell Int. 2025 Jan 20;25(1):20. doi: 10.1186/s12935-025-03649-6.
5
Circadian rhythms and breast cancer: from molecular level to therapeutic advancements.
J Cancer Res Clin Oncol. 2024 Sep 12;150(9):419. doi: 10.1007/s00432-024-05917-w.
6
Crosstalk between Circadian Rhythm Dysregulation and Tumorigenesis, Tumor Metabolism and Tumor Immune Response.
Aging Dis. 2024 Jul 2. doi: 10.14336/AD.2024.0533.
7
Elucidation of clinical implications Arising from circadian rhythm and insights into the tumor immune landscape in breast cancer.
Heliyon. 2024 Mar 6;10(6):e27356. doi: 10.1016/j.heliyon.2024.e27356. eCollection 2024 Mar 30.
8
Circadian Gene Variants in Diseases.
Genes (Basel). 2023 Aug 27;14(9):1703. doi: 10.3390/genes14091703.
9
Circadian Rhythm Dysregulation and Leukemia Development: The Role of Clock Genes as Promising Biomarkers.
Int J Mol Sci. 2022 Jul 26;23(15):8212. doi: 10.3390/ijms23158212.
10
Disturbance of the Circadian System in Shift Work and Its Health Impact.
J Biol Rhythms. 2022 Feb;37(1):3-28. doi: 10.1177/07487304211064218. Epub 2021 Dec 30.
本文引用的文献
1
Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma.
Int J Cancer. 2007 Jan 15;120(2):432-5. doi: 10.1002/ijc.22321.
2
Circadian clock coordinates cancer cell cycle progression, thymidylate synthase, and 5-fluorouracil therapeutic index.
Mol Cancer Ther. 2006 Aug;5(8):2023-33. doi: 10.1158/1535-7163.MCT-06-0177.
3
Circadian variation in endothelial function is attenuated in postmenopausal women.
Maturitas. 2006 Jun 20;54(3):294-303. doi: 10.1016/j.maturitas.2005.12.005. Epub 2006 Feb 8.
4
Breast cancer and night work among Norwegian nurses.
Cancer Causes Control. 2006 Feb;17(1):39-44. doi: 10.1007/s10552-005-3639-2.
5
Circadian disruption and breast cancer: from melatonin to clock genes.
Epidemiology. 2005 Mar;16(2):254-8. doi: 10.1097/01.ede.0000152525.21924.54.
6
Period3 structural variation: a circadian biomarker associated with breast cancer in young women.
Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):268-70.
7
A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells.
Cancer Res. 2003 Nov 1;63(21):7277-83.
8
Altered patterns of sleep and behavioral adaptability in NPAS2-deficient mice.
Science. 2003 Jul 18;301(5631):379-83. doi: 10.1126/science.1082795. Epub 2003 Jul 3.
9
The circadian clock: pacemaker and tumour suppressor.
Nat Rev Cancer. 2003 May;3(5):350-61. doi: 10.1038/nrc1072.
10
Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference.
Neuropsychopharmacology. 2003 Apr;28(4):734-9. doi: 10.1038/sj.npp.1300121. Epub 2002 Dec 3.
Zotero 插件